Search research articles
Contact Us
Filters
Showing results (451-460 of 511) with videos related to
Page
of 52
Sort By:
Mucosal Immunology
|
January 5, 2017
Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract
C M Posavad, L Zhao, L Dong, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1986
Etiology of cervical inflammation
J Paavonen, C W Critchlow, T DeRouen, et al.
Human Gene Therapy
|
June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology
S R Riddell, P D Greenberg, R W Overell, et al.
The Journal of Infectious Diseases
|
August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network
B S Graham, R B Belshe, M L Clements, et al.
Antiviral Research
|
September 29, 2004
HSV shedding
S L Sacks, P D Griffiths, L Corey, et al.
The New England Journal of Medicine
|
October 15, 1987
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer
J R Daling, N S Weiss, T G Hislop, et al.
Antiviral Research
|
September 29, 2004
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?
S L Sacks, P D Griffiths, L Corey, et al.
Antiviral Research
|
September 29, 2004
Lessons from HIV and hepatitis viruses
S L Sacks, P D Griffiths, L Corey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein
E L Cooney, M J McElrath, L Corey, et al.
Antiviral Research
|
September 29, 2004
HSV-2 transmission
S L Sacks, P D Griffiths, L Corey, et al.
Page
of 52
Search research articles
Search
Showing results (451-460 of 511) with videos related to
Sort By:
Page
of 52
Mucosal Immunology
|
January 5, 2017
Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract
C M Posavad, L Zhao, L Dong, et al.
American Journal of Obstetrics and Gynecology
|
March 1, 1986
Etiology of cervical inflammation
J Paavonen, C W Critchlow, T DeRouen, et al.
Human Gene Therapy
|
June 1, 1992
Phase I study of cellular adoptive immunotherapy using genetically modified CD8+ HIV-specific T cells for HIV seropositive patients undergoing allogeneic bone marrow transplant. The Fred Hutchinson Cancer Research Center and the University of Washington School of Medicine, Department of Medicine, Division of Oncology
S R Riddell, P D Greenberg, R W Overell, et al.
The Journal of Infectious Diseases
|
August 11, 1992
Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network
B S Graham, R B Belshe, M L Clements, et al.
Antiviral Research
|
September 29, 2004
HSV shedding
S L Sacks, P D Griffiths, L Corey, et al.
The New England Journal of Medicine
|
October 15, 1987
Sexual practices, sexually transmitted diseases, and the incidence of anal cancer
J R Daling, N S Weiss, T G Hislop, et al.
Antiviral Research
|
September 29, 2004
Introduction: Is viral shedding a surrogate marker for transmission of genital herpes?
S L Sacks, P D Griffiths, L Corey, et al.
Antiviral Research
|
September 29, 2004
Lessons from HIV and hepatitis viruses
S L Sacks, P D Griffiths, L Corey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 1, 1993
Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein
E L Cooney, M J McElrath, L Corey, et al.
Antiviral Research
|
September 29, 2004
HSV-2 transmission
S L Sacks, P D Griffiths, L Corey, et al.
Page
of 52